Company
Zenas BioPharma, Inc. (ZBIO)
Standardized SEC financial data for Zenas BioPharma, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001953926 · NASDAQ · Pharmaceutical Preparations.
Operating margin
-1000.0%
Net margin
-1000.0%
Revenue growth (YoY)
100.0%
Return on equity
-156.0%
ROIC
-144.0%
Free cash flow
-$172.4M
Debt / equity
0.33×
Current ratio
5.61×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $50.0M | $5.0M | $10.0M |
| R&D expense | $60.0M | $139.1M | $168.1M |
| SG&A expense | $17.1M | $29.7M |
Balance sheet
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | $67.3M | $56.9M | $350.8M | $360.5M |
| Total current assets | — | $59.8M | $355.9M | $351.2M |
Cash flow
| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Operating cash flow | -$30.5M | -$119.7M | -$172.3M |
| Capital expenditures | $17K | $131K | $18K |
| Free cash flow | -$30.5M | -$119.8M |
Get ZBIO data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/ZBIO/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/ZBIO/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"